ALKERMES | ALKS - 销售毛利

股票价格

37.26

每天变化

0.26 0.70%

每月一次

8.85%

每年

17.65%

Q2 预测

36.35

金融业

USD

USD 4.26B

现金及等价物

USD 351.55M

USD 73.25M

USD 1.36B

USD 599.5M

USD 1.58B

股息收益率

0

USD -48.28M

USD 80.26M

1.8K

EPS每股收益

USD -0.4

股本和储备

USD 1.75B

USD 331.33M

债务利息支出

USD 20.89M

USD 8.54M

USD 1.48B

USD 5.99B

USD -66.48M

USD 1.75B

USD -48.28M

普通股股本

USD 166.46M

39.33

USD -61.93M

USD 392.91M

销售和管理费用

USD 264.59M

USD 336.7M

贸易债权人

USD 102.36M

应收帐款人

USD 407.63M

	销售毛利	更改		日
AbbVie	USD 12.54B		474M	2026-03
Acadia Pharmaceuticals	USD 243.27M		14.49M	2026-03
ALKERMES	USD 331.33M		7M	2026-03
Amgen	USD 6.89B		415M	2025-12
Biogen	USD 1.82B		169.5M	2026-03
BioMarin Pharmaceutical	USD 571.21M		141.8M	2026-03
Bristol-Myers Squibb	USD 8.41B		381M	2025-12
Coherus Biosciences	USD 8.7M		853K	2025-12
Eli Lilly	USD 15.92B		1.33B	2025-12
Gilead Sciences	USD 5.52B		791M	2026-03
Heron Therapeutics	USD 29.47M		3.17M	2025-12
Ionis Pharmaceuticals	USD 243M		48M	2026-03
J&J	USD 17.24B		642M	2026-03
Merck	USD 10.85B		2.57B	2025-12
Minerva Neurosciences	-4.27M		26.79M	2024-12
Nektar Therapeutics	USD 21.81M		8.06M	2025-12
Neurocrine Biosciences	USD 800.7M		12.8M	2026-03
Otsuka Holdings	JPY 456.25B		1.16B	2026-03
Pfizer	USD 11.04B		1.24B	2026-03
Regeneron Pharmaceuticals	USD 2.94B		363.7M	2026-03
Vertex Pharmaceuticals	USD 2.6B		121.7M	2026-03